#416 ‒ The science of mitochondria: their role in health, aging, and disease, and what the evidence says about drugs and supplements aimed at improving their function | Navdeep Chandel, Ph.D.
01:28:01But I like the inflammation and the lowering glucose as the two actionable ones.
01:28:06And is there anything else that really can do that?
01:28:08Well, I think if you're lowering CHIP, that's pretty interesting.
01:28:11Yeah, yeah. We'll have to see how well that manages.
01:28:15And that hasn't been demonstrated in human cells yet?
01:28:18Well, it has. It has been also demonstrated in the UK Biobank as just a correlation.
01:28:23But it hasn't been proactively tested in humans?
01:28:25No, no, no. You mean as a clinical trial? No. Someone used to do that, but it'll take five years.
01:28:31But that would be a very interesting trial in a high-risk population.
01:28:34You take a high-risk cardiovascular disease population that is otherwise well-managed.
01:28:38Because one of the questions I find interesting in ASCVD is, I'm interested in the topic of
01:28:42residual risk. So why is it that some people can have significant risk, then you manage them well
01:28:51with blood pressure and lipid control, but then they still progress, disease progression occurs
01:28:56at different rates. There's some residual risk beyond the ApoB and beyond the hypertension,
01:29:02and let's assume they're not smoking. And how much of that is chip related?
01:29:05And if you can find that population and you do an RCT there with and without metformin and you track the hematopoiesis, the clonal hematopoiesis question, I think that could be very interesting.
01:29:18Yeah. By the way, speaking of heart disease or heart failure, speaking of metabolism, one of the best new drugs are these SGL2 inhibitors. The SGL2 is basically in the kidney. So you pee out, they call it sweet pee.
01:29:31The urine, you just pee out the glucose into the urine and that somehow is communicating to the
01:29:37heart and telling it, a failed heart, that you're good to go now. The idea that heart failure is
01:29:43due to mitochondrial dysfunction is the one I really have my doubts side in humans. I just
01:29:47don't think the evidence really points to that. You can make a mouse model where the heart fails
01:29:52because the mitochondria are failing. Right, but that doesn't mean that's...
01:29:55That's what's happening. And the results are mixed in humans. But the best evidence to me is that
01:30:00you put somebody on an SGL2 inhibitor, it somehow globally reprograms their metabolism. And that's
01:30:06a very loosey-goosey, non-mechanistic term. Maybe increases a little ketones or fatty acids,
01:30:12but their heart works fine now, which means there could not have been intrinsic mitochondrial
01:30:16defects. Because if there were, SGL2 inhibitors wouldn't work so well.
01:30:20Now, I want to talk about a whole bunch of supplements that get talked about a lot.
01:30:24Before I do, though, I just want to go back to something you said at the outset. I asked you,
01:30:27how would you measure mitochondrial function? And you said, I'd put a needle in somebody and
01:30:32pull out tissue. But that's important because there are lots of people out there that are
01:30:37hawking tests that are claiming they have tests. They have blood tests. They have breath tests.
01:30:42They have all sorts of tests to measure mitochondrial function. As one of the world's
01:30:46experts on this topic, are you aware of any blood test, breath test, any sort of test that a person
01:30:54can do to measure their mitochondrial function? If they see this, what should they be thinking?
01:30:58I have not looked at all these tests. I don't follow these tests. I don't care to. Simply
01:31:03because in a perfect world, I can't think of how I would design it for all the reasons we just
01:31:09talked about. That's the real problem. I mean, look, if I had one, then maybe this struggling
01:31:13scientist professionally and personally would come up with one, Peter. But I got nothing other
01:31:18than a cheap drug called metformin and a glucose monitor. It's difficult for me to imagine how that
01:31:23test looks like and whether it reproducibly measures something that has value? I'm assuming
01:31:29what these tests are trying to measure are... This content? Well, yeah, I assume, I'm also not an
01:31:35expert in this whatsoever. I assume they're measuring metabolic intermediates and they're
01:31:40somehow trying to impute based on your orginine, arnithine, citrulline levels, alpha-ketoglutarate
01:31:47levels. Oh, based on that, based on the ratios and levels of all these things, we can tell you
01:31:51how your mitochondrial function. Or acylcarnitine. Yeah. Why is that bogus in your mind? Well,
01:31:57because A is in steady state. It doesn't really tell you flux, which is how fast the system is
01:32:02running or not running. You could see an increase in something. Is that because you're running so
01:32:06fast and you still have a lot or is it something backed up? That's problem one. Yep. That's the
01:32:11whole CTAP inhibitor problem back when we were dealing with that drug. Yeah. So it's just when
01:32:16And I myself haven't done a deep dive on something.
01:32:19I generally try not to be overly critical, but I'm just making a conceptual point that
01:32:25if you and I sat together for an afternoon and said, here now, tell me all the things
01:32:29I could measure and how would I measure it?
01:32:40We didn't touch cancer because this is another misnomer.
01:32:42So the original hypothesis of cancer, the number one hypothesis of cancer, not number one, but the oldest from the 1920s was by a gentleman in the Warburg, a fact that many people have heard.
01:32:54So Otto Warburg got a Nobel Prize for the discovery of cytochrome C oxidase, which is the main oxygen-consuming enzyme of the electron transport chain.
01:33:03He truly did his PhD on cytochrome oxidase kinetics.
01:33:06So for me, Otto Warburg has a place for the discovery of that enzyme electron transport chain.
01:33:12So Otto Warburg, in the 1920s, noticed that cancer tissues, those make a lot of lactate
02:02:03The best case scenario would be all three. That's what the genomics people did. There's0.91
02:02:07biotech and genomics for sequencing machines that people buy. There's biotech for the drugs,
02:02:13but the basic science comes from the government, and then you have the philanthropy
02:02:17filling in all the holes. I'm just saying, yes, there is parts of it, but it isn't to scale.
02:02:22And I know people are down on academia. I would argue we should double-triple our money for biomedical research. So the last 10 years that you talk about, which I completely agree, is what we want to save. And if we don't have a healthy population the last 10 years, we're going to bankrupt the nation because of healthcare costs. You know it and I know it as people live.
02:02:42At the same time, I'm on record of saying this, and probably you'll get some flack for this,
02:02:47you have the right, Peter, you do, and the taxpayers, and say, you know what? Are you
02:02:51being as efficient, or are you being as innovative as you should be for the 21st century in academia's
02:02:57current model? And I don't think we are. I think it's time that academia change how its business
02:03:03model runs, but at the same time, give us three times as much money in return, okay? So I'm not
02:03:08saying just give us money, and we'll keep on doing what we did. We need to change. We need a new model
02:03:12a new system. I'm very open about it. I will encourage, I know you do notes, I hope you put
02:03:17this, the grand people in science 10 years ago, people who ran Princeton, NIH director, Nobel
02:03:23Prize, there's four of them, who wrote something called Rescuing the Biomedical Research Enterprise,
02:03:28rescuing. They wrote like a white paper in the Proceedings of the National Academy of Sciences
02:03:33because they're National Academy members, and they outlined what they thought were the problems
02:03:38and solutions. I am not saying we all have to agree on their solutions or even the problems.
02:03:42but it's a pretty good start. And that was 12 years ago.
02:05:34This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice.